Skip to main content

CRISPR, Vertex launch first company-backed gene editing trial in humans

The start of the study is a landmark moment for the experimental technology.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.